AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -87.5% | 398 | -82.2% | 0.00% | -100.0% |
| Q1 2022 | $32,000 | +113.3% | 2,242 | +244.9% | 0.00% | – |
| Q3 2021 | $15,000 | -77.9% | 650 | -76.1% | 0.00% | -100.0% |
| Q2 2021 | $68,000 | +750.0% | 2,723 | +951.4% | 0.00% | – |
| Q1 2021 | $8,000 | -46.7% | 259 | -56.5% | 0.00% | -100.0% |
| Q4 2020 | $15,000 | -11.8% | 595 | +5.1% | 0.00% | -50.0% |
| Q3 2020 | $17,000 | +88.9% | 566 | +55.5% | 0.00% | +100.0% |
| Q2 2020 | $9,000 | +800.0% | 364 | +1113.3% | 0.00% | – |
| Q1 2020 | $1,000 | -85.7% | 30 | -91.0% | 0.00% | -100.0% |
| Q4 2019 | $7,000 | -90.9% | 332 | -91.7% | 0.00% | -90.5% |
| Q2 2019 | $77,000 | – | 4,008 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |